NASA Names Four Astronauts for First Boeing, SpaceX U.S. Commercial Spaceflights
NASA has selected experienced astronauts Robert Behnken, Eric Boe, Douglas Hurley and Sunita Williams to work closely with The Boeing Company and SpaceX to develop their crew transportation systems and provide crew transportation services to and from the International Space Station. Credits: NASA
NASA today (July 9) named the first four astronauts who will fly on the first U.S. commercial spaceflights in private crew transportation vehicles being built by Boeing and SpaceX, marking a major milestone towards restoring American crew launches to U.S. soil as soon as mid-2017, if all goes well.
The four astronauts chosen are all veterans of flights on NASA’s Space Shuttles and to the International Space Station (ISS); Robert Behnken, Eric Boe, Douglas Hurley and Sunita Williams and now form the core of the NASA’s commercial crew astronaut corps. (…)
Read the rest of NASA Names Four Astronauts for First Boeing, SpaceX U.S. Commercial Spaceflights (1,196 words)
© Ken Kremer for Universe Today, 2015. | Permalink | No comment |
Post tags: Atlas V rocket, Boeing, boeing CST 100, cape canaveral, cargo dragon, CCP, CCtCAP, Commercial Crew, commercial crew program, Crew Dragon, Falcon 9 rocket, Falcon 9 rocket explosion, inflight abort test, International Space Station (ISS), ISS, NASA, pad abort test, SpaceX, STS-135
Feed enhanced by Better Feed from Ozh
Source: http://www.universetoday.com/121271/nasa-names-four-astronauts-for-first-boeing-spacex-u-s-commercial-spaceflights/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
